๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› India
Clinical trial register · India

Studies with an Indian investigative site

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1126 matching records held by the registry are in this view. Synced 23 Sep 2026, 03:16 UTC
1126
Studies in scope
all four open statuses
611
Recruiting now
open to new participants
222
Lead sponsors
across recruiting studies
Top sites
New Delhi 334 Mumbai 258 Hyderabad 237 Bangalore 195 Pune 189
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca100 Institute of Liver and Biliary Sciences, India48 Postgraduate Institute of Dental Sciences Rohtak45 Novartis Pharmaceuticals44 Tata Memorial Centre41
Site location
New Delhi334 Mumbai258 Hyderabad237 Bangalore195 Pune189
All 273 locations
Target enrolment
to
1126 of 1126 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Active, closed
A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)
NCT03992430Muscular Dystrophy, Duchenne
Sarepta Therapeutics, Inc.
Phase 3
160
Ahmedabad, Bengaluru, Hyderabad, Madurai, New Delhi, Pune, Vellore
2020-07-13
Active, closed
Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naรฏve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)
NCT04314531Active Psoriatic Arthritis
Sun Pharmaceutical Industries Limited
Phase 3
296
Surat, Bangalore, Belagavi, Hubli, Pune, Hyderabad, Lucknow, Kochi
2020-07-01
Active, closed
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
NCT04273945Pulmonary Arterial Hypertension
Actelion
Phase 3
935
Ahmedabad, Bangalore, Chengalpetu, Coimbatore, Durgapur, Hyderabad, Hyderbad, Kolkata
2020-06-30
Active, closed
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
NCT04232553Crohn's Disease
Eli Lilly and Company
Phase 3
996
Chandigarh, Surat, Pune, New Delhi, Ludhiana, Jaipur, Chennai
2020-06-22
Recruiting
Palliative Radiation for Advanced Cervical Cancer
NCT03997110Cervical Cancer
Tata Memorial Hospital
Not applicable
230
Mumbai
2020-06-19
Active, closed
KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer
NCT03946202Breast Cancer
Institute of Cancer Research, United Kingdom
Phase 2
184
Trivandrum, Vellore, Kolkata, Mumbai
2020-06-16
Active, closed
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer
NCT04269200Endometrial Neoplasms
AstraZeneca
Phase 3
805
Hisar, Mumbai
2020-05-05
Recruiting
EORTC Metastatic Breast Cancer Module Development
NCT07806266Metastatic Beast Cancer
University of Leeds
Observational
568
Mumbai
2020-05-01
Recruiting
Standard Maintenance Therapy (SMT) vs Local Consolidative Radiation Therapy and SMT in OM-NSCLC
NCT05278052Oligometastatic Disease, Metastatic Non Small Cell Lung Cancer
Tata Memorial Hospital
Phase 3
190
Mumbai
2020-04-20
Active, closed
Personal Health Train for Radiation Oncology in India and The Netherlands
NCT04655469Head and Neck Carcinoma
Maastricht Radiation Oncology
Observational
2,000
Bengaluru, Mumbai
2020-04-10
Recruiting
Randomised Evaluation of COVID-19 Therapy
NCT04381936Pneumonia
University of Oxford
Phase 3
70,000
New Delhi
2020-03-19
Active, closed
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)
NCT04088396Systemic Juvenile Idiopathic Arthritis
Eli Lilly and Company
Phase 3
58
New Delhi
2020-02-12
Active, closed
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
NCT04211337Medullary Thyroid Cancer
Loxo Oncology, Inc.
Phase 3
291
Thiruvananthapuram, Nashik, Pune, Kolkata, Chandigarh
2020-02-11
Recruiting
A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma
NCT04250064DIPG
Tata Memorial Centre
Phase 2
40
Mumbai
2020-02-04
Recruiting
First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)
NCT04638790Hodgkin Lymphoma, Adult
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
Phase 3
300
Mumbai
2020-02-01
Active, closed
A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis
NCT03997786Moderate-to-severe Chronic Plaque Psoriasis
Sun Pharmaceutical Industries Limited
Phase 2/3
135
Ahmedabad, Lucknow, Surat
2020-01-15
Active, closed
Deflazacort Vs. Prednisolone in Acute-stage ABPA
NCT04227483Allergic Bronchopulmonary Aspergillosis
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 2/3
150
Chandigarh
2020-01-15
Recruiting
VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer
NCT04057209Glottis Tumor, Larynx Cancer
Olgun Elicin
Not applicable
34
Mumbai
2019-11-20
Active, closed
A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastinยฎ in Advanced Non-squamous Non-small Cell Lung Cancer Patients
NCT03390686Lung Cancer, Non-small Cell Lung Cancer
Prestige Biopharma Limited
Phase 3
650
Nashik
2019-11-15
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
Novo Nordisk A/S
Phase 3
156
Bangalore, Pune, Jaipur, Ranipet
2019-11-13
Recruiting
Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC
NCT05277844Oligometastatic Disease, Non-small Cell Lung Cancer, Driver Mutation
Tata Memorial Hospital
Phase 2
106
Mumbai
2019-11-11
Recruiting
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (ฮฒ)-Thalassemia
NCT04143724Beta-Thalassemia
Celgene
Phase 2
99
Hyderabad, Mumbai, Nagpur, Noida, Kolkata, Vellore
2019-11-07
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors
NCT04083781Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
Novo Nordisk A/S
Phase 3
134
Bangalore, Pune, New Dehli, Ranipet, New Delhi
2019-10-21
Recruiting
Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry
NCT03991728Temporomandibular Joint Disorders
AO Innovation Translation Center
Observational
200
Bangalore, New Delhi
2019-10-15
Active, closed
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.
NCT03983954ER+ Breast Cancer, Ovarian Cancer, Cervical Squamous Cell Carcinoma, Pancreatic Adenocarcinoma
NeoTX Therapeutics Ltd.
Phase 1
120
Ahmedabad, Jhajjar, New Delhi, Udaipur, Hyderabad
2019-10-10
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Hyderabad, Ahmedabad, Bangalore, Gurgaon, New Delhi
2019-10-03
Active, closed
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
NCT03950232Ulcerative Colitis
Pfizer
Phase 3
896
Surat, Gurgaon, Nagpur, Pune, Jaipur, Kanpur
2019-09-05
Recruiting
PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)
NCT07185672Neuroendocrine Neoplasia's (NENs), Neuroendocrine Tumor GEP Grade 1-3, Neuroendocrine Gastroenteropancreatic Tumour
Tata Memorial Hospital
Phase 3
162
Mumbai, Navi Mumbai
2019-08-07
Active, closed
Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients
NCT03814746Sickle Cell Disease (SCD)
Novartis Pharmaceuticals
Phase 3
254
Bhubaneswar, Hyderabad
2019-07-26
Active, closed
A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropinยฎ Once a Day
NCT03878446Short Stature Children Born Small for Gestational Age (SGA)
Novo Nordisk A/S
Phase 2
62
Kochi, Pune, New Dehli
2019-07-04
Active, closed
A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)
NCT04035486Non-Small Cell Lung Cancer
AstraZeneca
Phase 3
587
Belagavi, Bengaluru, Gurgaon, Kolkata, New Delhi, Pune
2019-07-02
Active, closed
Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC
NCT03997123Triple Negative Breast Neoplasms
AstraZeneca
Phase 3
923
Bangalore, Gurgaon, Kolkata, Mumbai, Mysuru, Nagpur, Nashik, New Delhi
2019-06-25
Recruiting
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
NCT03968393Stroke, Atrial Fibrillation
Population Health Research Institute
Phase 4
2,270
North Guwฤhฤti, Ahmedabad, Bangalore, Alappuzha, Thrissur, Puducherry, Pune, Thiruvananthapuram
2019-06-14
Active, closed
Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients
NCT03568383Tuberculosis, MDR
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 3
5,832
Pune, Chennai
2019-06-03
Active, closed
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
NCT03709680Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor, Rhabdomyosarcoma
Pfizer
Phase 2
128
Gurugram, New Delhi
2019-05-24
Active, closed
ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy
NCT03769506Head and Neck Cancer
Rakuten Medical, Inc.
Phase 3
135
Vadodara, Bangalore, Kochi, Chennai, Hyderabad, Kolkata, Mumbai
2019-05-09
Active, closed
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
NCT03811561Diabetes Mellitus, Type 2
Novo Nordisk A/S
Phase 3
1,500
Guntur, Surat, Bangalore, Kochi, Thiruvananthapuram, Thiruvnanthapuram, Mumbai, Nagpur
2019-05-08
Active, closed
PROSpect: Prone and Oscillation Pediatric Clinical Trial
NCT03896763Acute Respiratory Distress Syndrome in Children
University of Pennsylvania
Not applicable
600
Hyderabad
2019-05-01
Active, closed
Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment
NCT03847428Hepatocellular Carcinoma
AstraZeneca
Phase 3
908
Bangalore, Hyderabad, Kolkata, Mumbai, New Delhi
2019-04-29
Recruiting
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
NCT03633708Secondary Hyperparathyroidism, Chronic Kidney Disease
Amgen
Phase 3
56
Bangalore, Belagavi, New Delhi, Kolkata
2019-04-29
Active, closed
Dietary Intake, Sarcopenic Obesity, and Other Treatment-Related Outcomes in Indian Children With Acute Lymphoblastic Leukemia
NCT03974893Sarcopenic Obesity
Columbia University
Observational
115
Mumbai
2019-04-18
Active, closed
Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)
NCT03875235Biliary Tract Neoplasms
AstraZeneca
Phase 3
810
Gurgaon, Kolkata, Mumbai, New Delhi
2019-04-16
Recruiting
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
NCT03773965Juvenile Idiopathic Arthritis
Eli Lilly and Company
Phase 3
190
Chennai, New Delhi, Vellore
2019-04-05
Recruiting
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
NCT03813407Hyperkalaemia
AstraZeneca
Phase 3
140
Bhubaneswar, Gurgaon, New Delhi
2019-04-02
Recruiting
One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer
NCT03788213Breast Cancer Female
Tata Medical Center
Not applicable
2,100
Kolkata
2019-03-26
Active, closed
Intra-operative Pancreatoscopy in Patients With IPMN
NCT03729453Intraductal Papillary Mucinous Neoplasm
Boston Scientific Corporation
Observational
100
Hyderabad
2019-03-20
Recruiting
Comparison of Anaesthesia Requirement for Ventilation With Endotracheal Tube Versus Proseal Laryngeal Mask Airway
NCT03812718Cholelithiases, Cholecystolithiasis
Sir Ganga Ram Hospital
Not applicable
160
New Delhi
2019-03-04
Recruiting
Distribution of Lymph Node Metastases in Esophageal Carcinoma
NCT03222895Esophageal Neoplasms, Lymph Node Metastases
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
5,000
Mumbai
2019-03-01
Active, closed
The Causal Effects of Old Age Pensions
NCT04029194Aging
National Bureau of Economic Research, Inc.
Not applicable
1,459
Chennai
2019-02-04
Recruiting
PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury
NCT04054414Acute Spinal Cord Injury
Pharmazz, Inc.
Phase 2
40
Belagavi, Kolkata, Lucknow, Nagpur, New Delhi
2019-01-10
Active, closed
Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib
NCT03778229Carcinoma
AstraZeneca
Phase 2
367
Bangalore, Chennai, Kolkata, New Delhi
2019-01-09
Active, closed
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX
NCT03754790Hemophilia
Genzyme, a Sanofi Company
Phase 3
281
Bangalore, Lucknow, Mumbai, Pune, Ranipet
2019-01-09
Active, closed
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
NCT03650114Relapsing Multiple Sclerosis
Novartis Pharmaceuticals
Phase 3
1,882
Mangalore, Kochi, Mumbai, Pune, New Delhi, Chandigarh, Hyderabad, Howrah
2018-12-28
Active, closed
Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)
NCT03775486Non-small Cell Lung Cancer NSCLC
AstraZeneca
Phase 2
401
Ahmedabad, Jamnagar, Kochi, Mysuru, Nashik, Pune, Thiruvananthapuram
2018-12-21
Active, closed
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
NCT03800134Non-Small Cell Lung Cancer
AstraZeneca
Phase 3
825
Ahmedabad, Gurgaon, Kolkata, Manipal, Mumbai, Mysuru, Namakkal, Nashik
2018-12-06
Active, closed
A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma
NCT03778957Hepatocellular Carcinoma
AstraZeneca
Phase 3
724
Bangalore, Bengaluru, Hyderabad, Kolkata, Madurai, Mumbai, Nashik, Pune
2018-11-30
Active, closed
A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients
NCT03706690Carcinoma, Non-Small-Cell Lung
AstraZeneca
Phase 3
407
Bangalore, Bengaluru, Karamsad, Kolkata, Nashik, Vadodara
2018-11-27
Active, closed
Safety and Efficacy of the ANTHEMโ„ข CR Total Knee System
NCT03885622Non-inflammatory Degenerative Joint Disease
Smith & Nephew Pte Ltd
Observational
153
Ahmedabad, Hisar, Mohali
2018-11-23
Active, closed
Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer
NCT03682068Unresectable Locally Advanced Urothelial Cancer, Metastatic Urothelial Cancer
AstraZeneca
Phase 3
1,246
Gurgaon, Hubli, Kolkata, Mysuru, Nagpur, Nashik, New Delhi, Pune
2018-09-27
Active, closed
Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy
NCT03703297Small Cell Lung Cancer
AstraZeneca
Phase 3
730
Bengaluru, Gurgaon
2018-09-27
Active, closed
The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial
NCT03447938Coronary Artery Disease
Ottawa Heart Institute Research Corporation
Not applicable
176
Bangalore, New Delhi
2018-09-01
Active, closed
A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)
NCT03521154Non Small Cell Lung Cancer (Stage III)
AstraZeneca
Phase 3
216
Bangalore, Gurgaon, Hubli, Karamsad, Kolkata, Nashik, New Delhi
2018-07-19
Active, closed
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
NCT03519945Ulcerative Colitis
Eli Lilly and Company
Phase 3
1,058
Ahmedabad, Bangalore, Hyderabad, Jaipur, Ludhiana, Nagpur, Noida, Pune
2018-07-18
Recruiting
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
NCT03671044Triple Negative Breast Cancer
Jina Pharmaceuticals Inc.
Phase 3
657
Vadodara
2018-07-10
Not yet open
Herbal Supplements for Improvement of Liver Function in Participants With Alcoholic Liver Disease
NCT03503708Alcoholic Liver Disease
Composite Interceptive Med Science
Not applicable
40
Bangalore
2018-05-30
Active, closed
Towards a Functional Cure for HBV - The COMMIT Cohort Study
NCT03645044Hiv, HBV Coinfection
University of Melbourne
Observational
102
Chennai
2018-05-24
Active, closed
Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial)
NCT03561961Prostate Adenocarcinoma
Tata Memorial Centre
Not applicable
526
Navi Mumbai
2018-05-24
Active, closed
International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer
NCT03386734Cervical Cancer
Centre Hospitalier Universitaire de Besancon
Not applicable
989
Hyderabad, Kolkata
2018-05-03
Recruiting
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
NCT03295981Giant Cell Tumor of Bone
St. Louis University
Phase 3
120
New Delhi
2018-05-03
By invitation
International Registry of Congenital Portosystemic Shunt (IRCPSS)
NCT06041906Congenital Portosystemic Shunt, CPSS (Congenital Portosystemic Shunt)
Prof. Valรฉrie Mc Lin
Observational
500
Kochi, New Delhi
2018-04-26
Active, closed
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
NCT03466411Crohn's Disease
Janssen Research & Development, LLC
Phase 2/3
1,409
Jaipur, New Delhi, Noida, Rajkot, Surat
2018-04-13
Active, closed
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
NCT03363373Neuroblastoma
Y-mAbs Therapeutics
Phase 2
122
Mumbai
2018-04-03
Active, closed
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
NCT03432286Episodic Migraine
Eli Lilly and Company
Phase 3
533
Mangalore, Nagpur, New Delhi, Pune
2018-03-14
Recruiting
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
NCT03549754Type 2 Diabetes, Hypertension, Chronic Kidney Disease, Heart Failure
AstraZeneca
Observational
35,000
Ahmedabad, Kolkata, Mumbai
2018-02-17
Active, closed
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
NCT03367702Stage II Prostate Adenocarcinoma AJCC v7
NRG Oncology
Phase 3
692
Mumbai
2018-02-01
Recruiting
NGS in Gallbladder Cancer and Response to Treatment
NCT05404347Gallbladder Cancer
Banaras Hindu University
Observational
100
Varanasi
2018-01-01
Recruiting
A Prospective Evaluation of the Peri-operative Hypoxia in Breast Cancer
NCT03797482Breast Cancer Female
Tata Memorial Hospital
Observational
500
Mumbai
2017-11-27
Active, closed
Efficacy Of Bovine Colostrum In The Treatment Of Severe Alcohol-Associated Hepatitis: A Randomized Controlled Trial
NCT02473341Alcoholic Hepatitis
Dayanand Medical College and Hospital
Phase 3
174
Ludhiana, Chandigarh, Hyderabad, Jaipur, New Delhi
2017-11-14
Recruiting
UNITY-B A Prospective, Multicentric, Single-arm Study to Evaluate the Safety and Efficacy of the UNITY-B Biodegradable Balloon-Expandable Biliary Stent System in Subjects With Biliary Strictures
NCT04929821Biliary Obstruction, Bile Duct Stricture, Bile Duct Diseases
QualiMed Innovative Medizinprodukte GmbH
Not applicable
100
Hyderabad
2017-10-16
Active, closed
Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
NCT03298451Hepatocellular Carcinoma
AstraZeneca
Phase 3
1,324
Bangalore, Bhubneshwar, Chennai, Hubli, Hyderabad, Karmsad, Mumbai, Nashik
2017-10-11
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
NCT03180268Grade 2 Meningioma, Intracranial Meningioma
NRG Oncology
Phase 3
163
Mumbai
2017-09-12
Active, closed
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
NCT03155997Breast Cancer
Eli Lilly and Company
Phase 3
5,637
Hyderabad, Ahmedabad, Vadodara, Gurgaon, Bangalore, Trivandrum, Mumbai, Nashik
2017-07-12
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
Swedish Orphan Biovitrum
Phase 3
407
Guwahati, Chandigarh, Surat, Gurgaon, Pune, Jaipur, Madurai, Hyderabad
2017-06-26
Recruiting
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
NCT03067181Childhood Extracranial Germ Cell Tumor, Extragonadal Embryonal Carcinoma, Germ Cell Tumor, Malignant Germ Cell Tumor
Children's Oncology Group
Phase 3
1,780
Mumbai
2017-05-25
Recruiting
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
NCT03141021Malignant Peripheral Nerve Sheath Tumors
Washington University School of Medicine
Observational
1,050
Mumbai
2017-04-28
Active, closed
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
NCT03052608Carcinoma, Non-Small-Cell Lung
Pfizer
Phase 3
296
Gurugram, Bangalore, Pune
2017-04-27
Recruiting
Newer Therapeutic Targets in Head and Neck Cancers
NCT05382585Head Neck Cancer, Oral Cancer
Banaras Hindu University
Observational
200
Varanasi
2017-04-01
Active, closed
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
NCT02682511Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited, Sclerosis, Progressive Systemic
Cumberland Pharmaceuticals
Phase 2
34
Chandigarh, Mumbai, Pune
2017-01
Active, closed
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
NCT02763566Breast Cancer
Eli Lilly and Company
Phase 3
463
Ahmedabad, Bangalore, Mumbai, Pune, New Delhi, Ranipet, Kolkata
2016-12-05
Recruiting
Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma.
NCT02964858NonHodgkin Lymphoma
Tata Memorial Hospital
Not applicable
840
Mumbai
2016-11
Active, closed
Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection
NCT02932150Chronic Hepatitis B
Gilead Sciences
Phase 2
150
Kolkata, Lucknow, Mumbai, Nagpur, New Delhi, Surat, Varanasi
2016-11
Recruiting
Clinical and Molecular Studies in Families With Inherited Eye Disease
NCT02771236Inherited Eye Disease
National Eye Institute (NEI)
Observational
5,000
Madurai
2016-10-04
Active, closed
Perioperative Therapy Preoperative Chemotherapy Versus Chemoradiotherapy in Locally Advanced Gall Bladder Cancers
NCT02867865Gall Bladder Cancers
Tata Memorial Hospital
Phase 2/3
124
Mumbai
2016-09-06
Active, closed
Prevalence and Incidence of Complications of Type One Diabetes in PUne At a Tertiary Care CentRE
NCT03069196Type 1 Diabetes Mellitus
Kem Hospital, Pune, India
Observational
323
Pune
2016-06-10
Active, closed
Bladder Cancer Adjuvant Radiotherapy Trial
NCT02951325Bladder Cancer, Urothelial Carcinoma Bladder
Tata Memorial Centre
Phase 3
153
Mumbai
2016-06-02
Recruiting
Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
NCT02823821End-Stage Kidney Disease
University of Sydney
Phase 4
50,000
Chฤซrฤla, Guntur, Gลซdลซr, Hindupur PPP, Kanigiri, Kฤkinฤda, Kurnool, Machilipatnam
2016-06
Recruiting
Trial Evaluating Role of Post Mastectomy Radiotherapy in Women With Node Negative Early Breast Cancer
NCT02992574Breastcancer
Tata Memorial Centre
Not applicable
1,022
Chandigarh, Kolhฤpur, Mumbai, Delhi, New Delhi, Jaipur
2016-05-27
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
NCT02735707Community-acquired Pneumonia, Influenza, COVID-19
UMC Utrecht
Phase 3
20,000
Chennai
2016-04-11
Recruiting
An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
NCT02754115Colorectal Cancer, Ovarian Cancer, Peritoneal Disease
Tata Memorial Centre
Observational
400
Mumbai
2016-04
By invitation
A Clinical Registry of Orthobiologics Procedures
NCT03011398Orthopedic Disorder
Regenexx, LLC
Observational
50,000
Hyderabad
2016-02
Rows per page Showing 1001–1100 of 1126
Previous 9 10 11 12 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-india?page=11

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (19) Obesity (16) Heart Failure (14) Carcinoma, Non-Small-Cell Lung (14) Overweight (13) Cervical Cancer (12) Non-Small Cell Lung Cancer (11) Liver Cirrhosis (10) Chronic Kidney Disease (9) Diabetes Mellitus, Type 2 (9) Ulcerative Colitis (8) Coronary Artery Disease (8) Periodontitis (7) Schizophrenia (7) Multiple Myeloma (7)
→

Browse trials by site location

New Delhi (334) Mumbai (258) Hyderabad (237) Bangalore (195) Pune (189) Kolkata (166) Ahmedabad (157) Nagpur (123) Jaipur (104) Chandigarh (104) Nashik (99) Delhi (97) Belagavi (91) Chennai (88) Surat (86)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.